The global Insert-tag-heregenotyping assay market was

New Post Public Reply Private Reply Replies (0) Message Board
dorotheapiper
254
The global Insert-tag-heregenotyping assay market was valued at over US$ 7 Bn. in 2017 and is expected to grow at a double digit CAGR during the forecasted period.
Market Definition: Genotyping Assay Market
 Genotyping is a technology that detects small genetic differences that may lead to major changes in phenotype, including physical differences that make us unique and pathological changes that can cause underlying disease. Genotyping determines differences in genetic complements by comparing a DNA sequence to that of another sample or a reference sequence and identifies small variations in genetic sequence within populations. However it should be noted that due to the current technological limitations, almost all genotyping is partial. It means that only a small fraction of an individual’s genotype is determined.
Get Your Free PDF Sample Copy @ https://www.marketindustryreports.com/pdf/7

 The global Genotyping Assay market is segmented by product & services, technique, end user, and region. The product and service segment is further segmented into Kits, reagents, Instruments and services. However, kits and reagents account for the largest market share in the following segment owing to development of personalized medicine as well as rise in genetic disorders. The technique segment can be further classified into PCR, sequencing and Electrophoresis. PCR accounts for the largest share in this segment due to the rise in PCR Technology. The End-User can be segmented into Diagnostics and Research Laboratories, Pharmaceuticals and Bio-Tech Companies. The pharmaceutical and Bio-tech companies dominate this segment with the largest share due to the fact that there is an increasing need for development of personalized medicines to counter the growing diseases related to genetic disorders.
Market drivers: Genotyping Assay Market
 The increasing genetic disorders
 The technological advancements in the genomic area
Market Restraints: Genotyping Assay Market
 The stringent regulatory policies
Key Developments: Genotyping Assay Market
The genotyping assay market is accelerating at a huge growth circle that promises a potential for diversified career opportunities.
Increasing R&D activities by the major players
Companies are taking R&D initiatives for the developments of innovative products to cater to the growing demands of the population. For instance, Fluidigm Corporation introduced Juno 96.96 Genotyping IFC, a product that analyzes huge number of DNA samples for the Single Nucleotide Polymorphisms (SNPs) in a very short time span.Moreover, genomics service is also provided by RTSF Genomics Core at Michigan State University, that offers genotyping service and technologies.
Key players in the global genotyping assay market are Thermo Fisher Scientific, Illumina, QIAGEN, Agilent Technologies, Danaher Corporation, Roche Diagnostics, GE Healthcare, Fluidigm Corporation, PerkinElmer, Eurofins Scientific, Bio-Rad Laboratories, Pacific Biosciences of California, GENEWIZ, and Integrated DNA Technologies
genotyping assay market market growth
The global genotyping assay market is propelled by a number of factors. One among them is the increase in the number of genetic diseases all around the world. Following that is the general awareness regarding personalized medicine all around the world especially in the developed regions of the world. According to the Parkinson’s Foundation, more than 60 thousand people are diagnosed with the major genetic disorder, Parkinson’s disease in the U.S. every year. Moreover, the number is expected to reach 1 million by 2020

About Market Industry Reports-

Market Industry Reports is a global leader in market measurement & advisory services, Market Industry Reports is at the forefront of innovation to address the worldwide industry trends and opportunities. We identified the caliber of market dynamics & hence we excel in the areas of innovation and optimization, integrity, curiosity, customer and brand experience, and strategic business intelligence through our research.

We continue to pioneer state-of-the-art approach in research & analysis that makes complex world simpler to stay ahead of the curve. By nurturing the perception of genius and optimized market intelligence we bring proficient contingency to our clients in the evolving world of technologies, megatrends and industry convergence. We empower and inspire Vanguards to fuel and shape their business to build and grow world-class consumer products.

Contact Us-
502, Sai Radhe, Kennedy Road,
Behind Hotel Sheraton Grand,
Near Pune Station, Pune 411 001
Email: sales@marketindustryreports.com
Phone: + 91 967353933
Website: https://www.marketindustryreports.com/latest-...s?pageno=8
Follow Us- LinkedIn | Twitter | Google+ | Face book
Scroll down for more posts ▼

Top 10 Most Recent News Articles

PenFed Credit Union's Soaring Loan Originations in Q3 2026

Updated Category News Views 52

Staggering Growth in Loan Originations Ever wake up to an unexpected windfall? That's the kind of headline PenFed Credit Union is writing with its $8.8 billion in year-to-date loan originations by the end of September 2026. Up 22% year-over-year, folks. Those numbers don't just happen by accident. That's hitting the nail on the head in the credit union world. Mortgage and...

Continue Reading
AstroRad Vest Makes Spaceflight History at Smithsonian

Updated Category News Views 58

Space Gear Finds a New Home In a move that brings a piece of the cosmos down to Earth, the AstroRad radiation protection vest, used by astronauts aboard the International Space Station (ISS), has landed a spot in the Smithsonian's National Air and Space Museum. It's not just some random hunk of tech; this vest represents a milestone in the annals of space gear — a...

Continue Reading
Cooper's Stock Takes a Beating: What's Behind It?

Updated Category News Views 37

A Shock to the System: Cooper's Rough Patch Not every day you see a stock take a body slam like this! Cooper Companies (NASDAQ: COO) got walloped after revealing some unsavory truths about its Q3 2026 performance. The market didn't just flinch—it reeled. On September 10, 2026, COO shares dove a steep $9.31—around a 14.6% free fall—whacking off over $1.7 billion in...

Continue Reading
Green Methanol: A $20.11B Market by 2032 Excites

Updated Category News Views 16

The Green Methanol Boom Folks, the money's about to get greener—greener methanol, that is. We’re talking about a market that’s set to explode from a humble $3.46 billion in 2026 to a jaw-dropping $20.11 billion by 2032. With a hefty CAGR of 34.1%, it seems like investors might want to buckle up for a bullish ride in this eco-friendly venture. Why Green Methanol?...

Continue Reading
Del Monte Faces Class Action Over Major Data Breach

Updated Category News Views 29

Data Breach Fallout Looms Over Del Monte Here's the scoop on Del Monte Foods facing what looks like a data breach debacle of epic proportions. Ransomware has hit the fan, and now folks are scrambling as Edelson Lechtzin LLP gears up to lay down some serious class action heat. From Cyber Shadows to Court Considerations This storm brewed on February 7, 2026. Del Monte’s...

Continue Reading
Cytrellis Boosts Aesthetics Training With Miami Partnership

Updated Category News Views 35

Cytrellis Partners with University of Miami The announcement from Cytrellis Biosystems is drawing some attention. The company's jumped into a new partnership with the University of Miami School of Nursing and Health Studies, looking to jazz up their Aesthetic Medicine Certificate Program. The kicker here is the introduction of Cytrellis' ellacor® system, a fancy bit of...

Continue Reading
BioArctic's Moves: Lecanemab Data and Leadership Insights

Updated Category News Views 60

BioArctic's Power Play: A Two-Pronged Update Ever feel like biotechnology is just a series of chess moves? BioArctic's recent maneuvers in the life sciences game certainly hint at that. First, they've got data brewing on lecanemab—this ain't small beans, folks, not with Alzheimer's disease in the crosshairs. Then there's their Nomination Committee. It’s like shaking...

Continue Reading
SCI Faces Investigation After Earnings Downgrade

Updated Category News Views 55

SCI's Rough Ride: Investors Brace for Impact There's nothing like waking up to find the stock you were banking on took a nosedive while you were dreaming of dividends. Service Corporation International (NYSE: SCI) sure gave shareholders more of a nightmare than a dream, slashing its earnings forecast for 2026 and watching its stock crumble by about 11.6% on October 29....

Continue Reading
Intestinal Worms: New Science and Old Challenges

Updated Category News Views 43

Intestinal Worms: A Modern Twist on an Old Tale Just when you thought you'd heard it all, here comes the notion that intestinal worms might actually be good for us. The stuff of cringe-worthy junior high biology classes is now strutting its stuff in F1000Research. Sounds odd? Maybe, but there's a half-century of science behind it. Old Foes with New Friends These...

Continue Reading
Gastops and Bell: A New Era in Aerospace Collaboration

Updated Category News Views 17

Gastops and Bell Seal a Forward-Looking Deal Who would've thought Gastops and Bell, two juggernauts in their respective fields, would link arms to drive the aerospace game forward in Canada? That's right, a Memorandum of Understanding (MOU) was inked between these titans at the 2026 Canadian Aerospace Summit, paving the way for collaboration on future programs. This isn't...

Continue Reading

Top 5 Most Recently Viewed Articles

Vitesse Energy's Q3 Performance and Future Prospects Examined

Updated Category News Views 65

Vitesse Energy's Third Quarter Highlights Vitesse Energy, Inc. (NYSE: VTS) recently shared its financial and operating results for the third quarter. The company reported a robust net income of $17.4 million alongside an adjusted net income of $7.6 million. The adjusted EBITDA reached $37.6 million, alongside operational cash flow exceeding $45.7 million, showcasing a...

Continue Reading
Capital One Financial Soars After Impressive Third-Quarter Gains

Updated Category News Views 307

Capital One's Remarkable Q3 Performance Capital One Financial Corp. (NYSE: COF) recently unveiled its third-quarter results, showcasing a strong financial performance that exceeded analysts' expectations. The report highlighted significant increases in both earnings and revenue, making a substantial impact on investor confidence and stock performance. Diving into the Key...

Continue Reading
Recent Developments Boost Travere Therapeutics' Market Outlook

Updated Category News Views 83

Update on Travere Therapeutics On a recent Wednesday, Stifel maintained its Hold rating for Travere Therapeutics (NASDAQ:TVTX) while raising the price target to $13.00 from the previous $10.00. This adjustment is a result of a thorough analysis of the company's recent progress, specifically focusing on their drug candidate, Sparsentan. Significance of the PARASOL Workshop...

Continue Reading
Kahoot! Achieves Gold Certification in Educational Equity

Updated Category News Views 106

Kahoot! Achieves Gold Certification in Educational Equity Kahoot!, the renowned education technology platform, has recently been awarded the prestigious ICEIE Gold certification for its unwavering commitment to equity in education. This recognition emphasizes the company's dedication to ensuring that all learners have access to quality educational tools and resources,...

Continue Reading
Spicewood Mineral Partners Expands Holdings with New Acquisitions

Updated Category News Views 91

Spicewood Mineral Partners Expands Holdings in the Permian Basin Spicewood Mineral Partners, a prominent mineral and energy investment firm based in Dallas, has made exciting updates regarding its latest acquisitions in the Delaware Basin. The company has recently targeted a selection of high-quality "tier 1" mineral assets in the Permian Basin, showcasing a strategic...

Continue Reading